Changes in the concentration of EGFR-mutated plasma DNA in the first hours of anti-EGFR therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. Вопр. онкол. [Internet]. 2021 Oct. 29 [cited 2026 Oct. 14];67(5):665-74. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1292